» Articles » PMID: 2429666

Morphine Metabolism in Isolated Rat Hepatocytes and Its Implications for Hepatotoxicity

Overview
Date 1986 Oct 15
PMID 2429666
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Isolated rat hepatocytes metabolized morphine to its glucuronide conjugate, morphinone-glutathione conjugate, normorphine and morphinone. Addition of morphine to the isolated hepatocytes induced a marked decrease in the level of glutathione in the cells and resulted in cell death. The formation of glutathione conjugate was correlated well with the loss of intracellular glutathione. The cytotoxicity of morphinone was higher than that of morphine. Naloxone and normorphine showed no cytotoxic effect on the cells. Naloxone inhibited the formation of morphinone-glutathione conjugate and prevented the morphine-induced cytotoxicity. Naloxone also blocked morphine-induced liver damage in vivo. In contrast, the morphinone-induced hepatotoxicity was not prevented by naloxone. It is concluded that morphine has a hepatotoxic effect, that the morphine-induced hepatotoxicity is due to its metabolic activation, and that naloxone acts as an inhibitor of an enzyme converting morphine to morphinone.

Citing Articles

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?.

Tarantino G, Cataldi M, Citro V Front Microbiol. 2024; 15:1319897.

PMID: 39687876 PMC: 11646994. DOI: 10.3389/fmicb.2024.1319897.


The Positive and Negative Outcome of Morphine and Disulfiram Subacute Co-Administration in Rats in the Absence of Ethanol Challenge.

Fraczek K, Kowalczyk A, Pekala M, Kasarello K, Sygitowicz G, Sulejczak D Pharmaceutics. 2020; 13(1).

PMID: 33375279 PMC: 7823937. DOI: 10.3390/pharmaceutics13010029.


Opioid epidemic and liver disease.

Verna E, Schluger A, Brown Jr R JHEP Rep. 2020; 1(3):240-255.

PMID: 32039374 PMC: 7001546. DOI: 10.1016/j.jhepr.2019.06.006.


Changes in serum biochemical factors associated with opium addiction after addiction desertion.

Afarinesh M, Haghpanah T, Divsalar K, Dehyadegary E, Shaikh-Aleslami A, Mahmoodi M Addict Health. 2015; 6(3-4):138-45.

PMID: 25984281 PMC: 4354219.


Opium use and risk of mortality from digestive diseases: a prospective cohort study.

Malekzadeh M, Khademi H, Pourshams A, Etemadi A, Poustchi H, Bagheri M Am J Gastroenterol. 2013; 108(11):1757-65.

PMID: 24145676 PMC: 5752100. DOI: 10.1038/ajg.2013.336.